Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $1.7100 (-1.16%) ($1.7100 - $1.7100) on Fri. Nov. 26, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.1% (three month average) | RSI | 23 | Latest Price | $1.7100(-1.16%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -1.2% a day on average for past five trading days. | Weekly Trend | ANPC declines -14.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) XLF(19%) EMHY(18%) EWG(18%) EWP(18%) JNK(18%) | Factors Impacting ANPC price | ANPC will decline at least -3.05% in a week (0% probabilities). SIL(-24%) SLV(-22%) BNDX(-18%) GDXJ(-17%) GDX(-16%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.05% (StdDev 6.1%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $2.08 | 5 Day Moving Average | $1.71(0%) | 10 Day Moving Average | $1.71(0%) | 20 Day Moving Average | $2.08(-17.79%) | To recent high | -50.9% | To recent low | 4.3% | Market Cap | $15m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |